Teradyne Inc

TER: XNAS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
@!xLOCK|@B#LOCK|rPh<v&

Teradyne Earnings: Bullish AI Comments Bring Market Back In Line With Our Long-Term Rebound Thesis

Teradyne's second-quarter results met management guidance. Sales declined 11% year over year and 5% sequentially to $652 million. Third-quarter guidance implies a return to both year-over-year and sequential revenue growth, to a midpoint of $740 million.

Sponsor Center